CRH Medical Corp (NYSEAMERICAN:CRHM) – Equities researchers at Clarus Securities issued their Q1 2018 earnings estimates for shares of CRH Medical in a research report issued on Tuesday. Clarus Securities analyst N. Atkinson forecasts that the company will earn ($0.01) per share for the quarter.
Several other equities research analysts have also recently weighed in on the stock. Zacks Investment Research cut shares of CRH Medical from a “buy” rating to a “hold” rating in a research report on Monday, January 15th. Morgan Stanley upgraded shares of CRH Medical from an “equal weight” rating to an “overweight” rating in a research report on Friday, November 17th. Four equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. CRH Medical presently has an average rating of “Buy” and a consensus price target of $6.00.
Shares of CRH Medical (CRHM) opened at $3.25 on Wednesday. CRH Medical has a 12-month low of $1.46 and a 12-month high of $9.25. The firm has a market cap of $207.56, a price-to-earnings ratio of 46.43 and a beta of 1.14.
Large investors have recently bought and sold shares of the business. Ramsey Quantitative Systems acquired a new stake in CRH Medical in the fourth quarter worth $128,000. Vanguard Group Inc. acquired a new stake in CRH Medical in the second quarter worth $150,000. TD Asset Management Inc. grew its holdings in CRH Medical by 65.3% in the third quarter. TD Asset Management Inc. now owns 111,054 shares of the company’s stock worth $289,000 after purchasing an additional 43,851 shares during the period. Baird Financial Group Inc. acquired a new stake in CRH Medical in the fourth quarter worth $301,000. Finally, JPMorgan Chase & Co. grew its holdings in CRH Medical by 69.1% in the third quarter. JPMorgan Chase & Co. now owns 410,100 shares of the company’s stock worth $964,000 after purchasing an additional 167,600 shares during the period.
CRH Medical Company Profile
CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.